Corporate Profile

Inozyme Pharma, Inc. is a clinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of diseases impacting the vasculature, soft tissue, and skeleton. Inozyme is developing INZ-701, an enzyme replacement therapy, to address pathologic mineralization and intimal proliferation, which can drive morbidity and mortality in these severe diseases. INZ-701 is currently in clinical development for the treatment of ENPP1 Deficiency, ABCC6 Deficiency and calciphylaxis.

Stock Quote

$5.77

CHANGE+0.05 (0.87%)
VOLUME209,837
MAR 13, 2024 4:00PM
Data Provided by…

Press Releases

Events

May 03, 2024
Inozyme Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Read more

Apr 08, 2024
Inozyme Pharma Announces Positive Topline Data from Ongoing Phase 1/2 Trials of INZ-701 in Adults with ABCC6 Deficiency (PXE) and ENPP1 Deficiency
Read more

Apr 05, 2024
Inozyme Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Read more

4/9/2024 10:15 AM Eastern

23rd Annual Needham Virtual Healthcare Conference
Click Here for Webcast

4/8/2024 08:00 AM Eastern
INZ-701 Update Call
Click Here for Webcast
Presentation

3/4/2024 09:10 AM Eastern
44th Annual TD Cowen Health Care Conference (Orphan Bone & Neuromuscular Diseases Panel Discussion)
Click Here for Webcast

Headings

h1 tag

This is 2nd level heading – h2 tag

This is 3rd level heading – h3 tag

This is 4th level heading – h4 tag

This is 5th level heading
This is 6th level heading

Color Palette

Logo Colors

Neutrals

#ececec – grey

Accent Colors

Program Colors

#dab64a – changed 8 to b – yellow

Additional Colors

#d5ba55 – orange

#e380a7 – pink

#e2dbbc – beige (new)

Color Palette (OLD)

green #47af90

other green #9ea563

blue #028fae

bright blue #00aede

light blue #def6ff

pink #e380a7

red #ed6b5d

dark red #a2625e

cherry #c36191

orange #d58a55

yellow #dab64a

white #ffffff

grey #ecece

Basic block level elements

This is the ALT tag for the image
This is the caption for the image

TOGETHER WE… believe that MicroRNA therapeutics will become a major new class of drugs. We are focused on harnessing their power to target multiple pathways of disease.

This is a normal paragraph. To add some length to it, let us mention that this page was primarily written for testing the effect of user style sheets. You can use it for various other purposes as well, like just checking how your browser displays various HTML elements by default. It can also be useful when testing conversions from HTML format to other formats, since some elements can go wrong then. Dysregulated microRNA expression is a key factor in many complex multi-factoral diseases, including inflammatory disease, fibrosis, metabolic disease and cancer. microRNA therapeutics are oligonucleotides that modulate the function of microRNAs, correcting the imbalance of gene expression and associated cellular pathways to treat a broad range human disease.[blue_band]This is another paragraph. I think it needs to be added that the set of elements tested is not exhaustive in any sense.[/blue_band]

Balboa Park 1915 caption
Balboa Park 1915 caption

microRNAs are members of a large class of non-coding RNAs of approximately 22 nucleotides in length that regulate most genes in the genome. A single microRNA can target and regulate up to hundreds of genes and these genes are involved in biological networks or pathways.

[callout title=”” image=”http://dauntlessph.staging.wpengine.com/wp-content/themes/dauntless/images/dauntless-logo.png”]We design and create functional human tissues using our proprietary three-dimensional bioprinting technology.
“logo"[/callout]

I have selected those elements for which it can make sense to write user style sheet rules, in my opinion.

Lists

Ordered:

  • One.
  • Two.
  • Three. Well, probably this list item should be longer. Note that for short items lists look better if they are compactly presented, whereas for long items, it would be better to have more vertical spacing between items.
  • Four. This is the last item in this list. Let us terminate the list now without making any more fuss about it.

This is a paragraph before a numbered list (ol). Note that the spacing between a paragraph and a list before or after that is hard to tune in a user style sheet. You can”t guess which paragraphs are logically related to a list, e.g. as a “list header”.

Numbered:

  1. One.
  2. Two.
  3. Three. Well, probably this list item should be longer. Note that if items are short, lists look better if they are compactly presented, whereas for long items, it would be better to have more vertical spacing between items.
  4. Four. This is the last item in this list. Let us terminate the list now without making any more fuss about it.

Links

This is a text paragraph that contains some inline links. Generally, inline links (as opposite to e.g. links lists) are problematic from the usability perspective, but they may have use as “incidental”, less relevant links. See the document Links Want To Be Links.

Buttons

Tables

The following table has a caption. The first column contain table header cells (th elements) only; other cells are data cells with even/odd classes.

CountryTotal areaLand area
Denmark43,07042,370
Finland337,030305,470
Iceland103,000100,250
Norway324,220307,860
Sweden449,964410,928
table caption

Horizontal rule


Media & Text block